Mid-Year Report — ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES (2007)

Firm

ASSOCIATION FOR ACCESSIBLE MEDICINES

Client

ASSOCIATION FOR ACCESSIBLE MEDICINES

Income

—

Expenses

$420,000

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Office of Generic Drugs Appropriations - S.1859 and H.R. 3161

Lobbyist	Covered position, as disclosed
GARY HEIMBERG	N/A
KATHLEEN D JAEGER	N/A
BRUCE LOTT	N/A
JASON R MONEY	N/A
REILLY O'CONNOR	N/A

Contacted: SENATE; Food & Drug Administration (FDA); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR)

Bills named: S. 1859 (110th), H.R. 3161 (110th)

Medicare/Medicaid MMM

Medicaid Reimbursement - S.1951 and H.R.3140 S-Chip/Rebates - S.1893 and H.R. 3162

Lobbyist	Covered position, as disclosed
GARY HEIMBERG	N/A
KATHLEEN D JAEGER	N/A
BRUCE LOTT	N/A
JASON R MONEY	N/A
REILLY O'CONNOR	N/A

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); SENATE; Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1951 (110th), H.R. 3162 (110th), S. 1893 (110th), H.R. 3140 (110th)

Trade (domestic/foreign) TRD

Korea Free Trade Agreement Panama Free Trade Agreement Peru Free Trade Agreement Columbia Free Trade Agreement

Lobbyist	Covered position, as disclosed
GARY HEIMBERG	N/A
KATHLEEN D JAEGER	N/A
BRUCE LOTT	N/A
JASON R MONEY	N/A
REILLY O'CONNOR	N/A

Contacted: Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

Patent Reform - S.1195 and H.R.1908 Patent Settlements - S.316, H.R.1432 and H.R. 1902

Lobbyist	Covered position, as disclosed
GARY HEIMBERG	N/A
KATHLEEN D JAEGER	N/A
BRUCE LOTT	N/A
JASON R MONEY	N/A
REILLY O'CONNOR	N/A

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Food & Drug Administration (FDA)

Bills named: S. 316 (110th), H.R. 1902 (110th), H.R. 1908 (110th), H.R. 1432 (110th), S. 1195 (110th)

Pharmacy PHA

Generic Biologics - S.623, S.1695, H.R. 1038, and H.R. 1956 Pediatric Exclusivity - S.1082 and H.R. 2900 Drug Safety - S.484 and S.1082 Authorized Generics - S.438 and H.R. 806 Citizen Petitions - S.1088 and S.25 Counterfeit Drugs - S.242, S.1082, H.R. 780 and H.R.2710

Lobbyist	Covered position, as disclosed
GARY HEIMBERG	N/A
KATHLEEN D JAEGER	N/A
BRUCE LOTT	N/A
JASON R MONEY	N/A
REILLY O'CONNOR	N/A

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 25 (110th), S. 242 (110th), S. 623 (110th), H.R. 2900 (110th), H.R. 1956 (110th), S. 1088 (110th), S. 484 (110th), H.R. 2710 (110th), H.R. 780 (110th), H.R. 806 (110th), S. 1695 (110th), H.R. 1038 (110th), S. 1082 (110th), S. 438 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.